Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development

FEBS Letters

Volumn 580, Issue 23, 2006, Pages 5588-5596

  Pennings, Marieke ^a   Meurs, Illiana ^a   Ye, Dan ^a   Out, Ruud ^a   Hoekstra, Menno ^a   Van Berkel, Theo J C ^a   Eck, Miranda Van ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

ABC transporters; Atherosclerosis; Cholesterol; Macrophages; Membrane lipid asymmetry; Scavenger receptors

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; CHOLESTEROL; MEMBRANE LIPID; MEMBRANE PROTEIN;

ATHEROSCLEROSIS; BONE MARROW CELL; CELL MEMBRANE; CELL MEMBRANE TRANSPORT; CELL SURFACE; CHOLESTEROL TRANSPORT; ENDOCYTOSIS; FOAM CELL; HOMEOSTASIS; HUMAN; MACROPHAGE; MEMBRANE TRANSPORT; NONHUMAN; PATHOGENESIS; PATHOLOGY; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SHORT SURVEY; TRANSPORT KINETICS;

ANIMALS; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CELL MEMBRANE; CHOLESTEROL; HOMEOSTASIS; HUMANS; MACROPHAGES;

EID: 33749043006     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.08.022     Document Type: Short Survey

References (132)

1. Hennekens C.H. Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors. Circulation 97 (1998) 1095-1102
2. Ross R. Atherosclerosis - an inflammatory disease. New Engl. J. Med. 340 (1999) 115-126
3. Naito M., Suzuki H., Mori T., Matsumoto A., Kodama T., and Takahashi K. Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am. J. Pathol. 141 (1992) 591-599
4. Matsumoto A., Naito M., Itakura H., Ikemoto S., Asaoka H., Hayakawa I., Kanamori H., Aburatani H., Takaku F., Suzuki H., et al. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 87 (1990) 9133-9137
5. Hiltunen T.P., Luoma J.S., Nikkari T., and Yla-Herttuala S. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation 97 (1998) 1079-1086
6. Suzuki H., Kurihara Y., Takeya M., Kamada N., Kataoka M., Jishage K., Ueda O., Sakaguchi H., Higashi T., Suzuki T., Takashima Y., Kawabe Y., Cynshi O., Wada Y., Honda M., Kurihara H., Aburatani H., Doi T., Matsumoto A., Azuma S., Noda T., Toyoda Y., Itakura H., Yazaki Y., Kodama T., et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386 (1997) 292-296
7. Lougheed M., Lum C.M., Ling W., Suzuki H., Kodama T., and Steinbrecher U. High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II. J. Biol. Chem. 272 (1997) 12938-12944
8. Van Berkel T.J., Van Velzen A., Kruijt J.K., Suzuki H., and Kodama T. Uptake and catabolism of modified LDL in scavenger-receptor class A type I/II knock-out mice. Biochem. J. 331 (1998) 29-35
9. Sakaguchi H., Takeya M., Suzuki H., Hakamata H., Kodama T., Horiuchi S., Gordon S., van der Laan L.J., Kraal G., Ishibashi S., Kitamura N., and Takahashi K. Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. Lab. Invest. 78 (1998) 423-434
10. Babaev V.R., Gleaves L.A., Carter K.J., Suzuki H., Kodama T., Fazio S., and Linton M.F. Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2593-2599
11. Herijgers N., de Winther M.P., Van Eck M., Havekes L.M., Hofker M.H., Hoogerbrugge P.M., and Van Berkel T.J. Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knockout mice. J. Lipid Res. 41 (2000) 1402-1409
12. Van Eck M., De Winther M.P., Herijgers N., Havekes L.M., Hofker M.H., Groot P.H., and Van Berkel T.J. Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on cholesterol levels and atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2600-2606
13. Van Berkel T.J., Out R., Hoekstra M., Kuiper J., Biessen E., and Van Eck M. Scavenger receptors: friend or foe in atherosclerosis?. Curr. Opin. Lipidol. 16 (2005) 525-535
14. Endemann G., Stanton L.W., Madden K.S., Bryant C.M., White R.T., and Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268 (1993) 11811-11816
15. Febbraio M., Abumrad N.A., Hajjar D.P., Sharma K., Cheng W., Pearce S.F., and Silverstein R.L. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem. 274 (1999) 19055-19062
16. Kunjathoor V.V., Febbraio M., Podrez E.A., Moore K.J., Andersson L., Koehn S., Rhee J.S., Silverstein R., Hoff H.F., and Freeman M.W. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 277 (2002) 49982-49988
17. Zhao Z., de Beer M.C., Cai L., Asmis R., de Beer F.C., de Villiers W.J., and van der Westhuyzen D.R. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 168-173
18. Febbraio M., Guy E., and Silverstein R.L. Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 2333-2338
19. Moore K.J., Kunjathoor V.V., Koehn S.L., Manning J.J., Tseng A.A., Silver J.M., McKee M., and Freeman M.W. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J. Clin. Invest. 115 (2005) 2192-2201
20. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., and Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271 (1996) 518-520
21. Out R., Hoekstra M., Spijkers J.A., Kruijt J.K., Van Eck M., Bos I.S., Twisk J., and Van Berkel T.J. Scavenger receptor class B type I is solely responsible for the selective uptake of cholesteryl esters from HDL by the liver and the adrenals in mice. J. Lipid Res. 45 (2004) 2088-2095
22. Ji Y., Jian B., Wang N., Sun Y., Moya M.L., Phillips M.C., Rothblat G.H., Swaney J.B., and Tall A.R. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272 (1997) 20982-20985
23. Chinetti G., Gbaguidi F.G., Griglio S., Mallat Z., Antonucci M., Poulain P., Chapman J., Fruchart J.C., Tedgui A., Najib-Fruchart J., and Staels B. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 101 (2000) 2411-2417
24. Hirano K., Yamashita S., Nakagawa Y., Ohya T., Matsuura F., Tsukamoto K., Okamoto Y., Matsuyama A., Matsumoto K., Miyagawa J., and Matsuzawa Y. Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. Circ. Res. 85 (1999) 108-116
25. Rigotti A., Acton S.L., and Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J. Biol. Chem. 270 (1995) 16221-16224
26. de la Llera-Moya M., Rothblat G.H., Connelly M.A., Kellner-Weibel G., Sakr S.W., Phillips M.C., and Williams D.L. Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface. J. Lipid Res. 40 (1999) 575-580
27. Yancey P.G., de la Llera-Moya M., Swarnakar S., Monzo P., Klein S.M., Connelly M.A., Johnson W.J., Williams D.L., and Rothblat G.H. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J. Biol. Chem. 275 (2000) 36596-36604
28. Gu X., Kozarsky K., and Krieger M. Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor. J. Biol. Chem. 275 (2000) 29993-30001
29. Covey S.D., Krieger M., Wang W., Penman M., and Trigatti B.L. Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1589-1594
30. Van Eck M., Bos I.S., Hildebrand R.B., Van Rij B.T., and Van Berkel T.J. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. Am. J. Pathol. 165 (2004) 785-794
31. Zhang W., Yancey P.G., Su Y.R., Babaev V.R., Zhang Y., Fazio S., and Linton M.F. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 108 (2003) 2258-2263
32. Koo C., Wernette-Hammond M.E., Garcia Z., Malloy M.J., Uauy R., East C., Bilheimer D.W., Mahley R.W., and Innerarity T.L. Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors. J. Clin. Invest. 81 (1988) 1332-2340
33. Perrey S., Ishibashi S., Kitamine T., Osuga J., Yagyu H., Chen Z., Shionoiri F., Iizuka Y., Yahagi N., Tamura Y., Ohashi K., Harada K., Gotoda T., and Yamada N. The LDL receptor is the major pathway for beta-VLDL uptake by mouse peritoneal macrophages. Atherosclerosis 154 (2001) 51-60
34. Brown M.S., and Goldstein J.L. Regulation of the activity of the low density lipoprotein receptor in human fibroblasts. Cell 6 (1975) 307-316
35. Herijgers N., Van Eck M., Korporaal S.J., Hoogerbrugge P.M., and Van Berkel T.J. Relative importance of the LDL receptor and scavenger receptor class B in the beta-VLDL-induced uptake and accumulation of cholesteryl esters by peritoneal macrophages. J. Lipid Res. 41 (2000) 1163-1171
36. Linton M.F., Babaev V.R., Gleaves L.A., and Fazio S. A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation. J. Biol. Chem. 274 (1999) 19204-19210
37. Multhaupt H.A., Gafvels M.E., Kariko K., Jin H., Arenas-Elliot C., Goldman B.I., Strauss III J.F., Angelin B., Warhol M.J., and McCrae K.R. Expression of very low density lipoprotein receptor in the vascular wall. Analysis of human tissues by in situ hybridization and immunohistochemistry. Am. J. Pathol. 148 (1996) 1985-1997
38. Nakazato K., Ishibashi T., Shindo J., Shiomi M., and Maruyama Y. Expression of very low density lipoprotein receptor mRNA in rabbit atherosclerotic lesions. Am. J. Pathol. 149 (1996) 1831-1838
39. Argraves K.M., Kozarsky K.F., Fallon J.T., Harpel P.C., and Strickland D.K. The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. J. Clin. Invest. 100 (1997) 2170-2181
40. Sakai J., Hoshino A., Takahashi S., Miura Y., Ishii H., Suzuki H., Kawarabayasi Y., and Yamamoto T. Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J. Biol. Chem. 269 (1994) 2173-2182
41. Van Eck M., Oost J., Goudriaan J.R., Hoekstra M., Hildebrand R.B., Bos I.S., Willems Van Dijk K., and Van Berkel T.J. Role of the macrophage very-low-density lipoprotein receptor in atherosclerotic lesion development. Atherosclerosis 183 (2005) 230-237
42. Lillis A.P., Mikhailenko I., and Strickland D.K. Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability. J. Thromb. Haemost. 3 (2005) 1884-1893
43. Hu L., Boesten L., Huisman M., Meidnets E., Havekes L., Van Vlijmen B., and Tamsma J. Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis. J. Vasc. Res. 42 Suppl. 2 (2005) 55
44. Jones N.L., and Willingham M.C. Modified LDLs are internalized by macrophages in part via macropinocytosis. Anat. Rec. 255 (1999) 57-68
45. Kruth H.S., Huang W., Ishii I., and Zhang W.Y. Macrophage foam cell formation with native low density lipoprotein. J. Biol. Chem. 277 (2002) 34573-34580
46. Kruth H.S., Jones N.L., Huang W., Zhao B., Ishii I., Chang J., Combs C.A., Malide D., and Zhang W.Y. Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein. J. Biol. Chem. 280 (2005) 2352-2360
47. Zhao B., Li Y., Buono C., Waldo S.W., Jones N.L., Mori M., and Kruth H.S. Constitutive receptor-independent low density lipoprotein uptake and cholesterol accumulation by macrophages differentiated from human monocytes with macrophage-colony-stimulating factor (M-CSF). J. Biol. Chem. 281 (2006) 15757-15762
48. Lewis W.H. Pinocytosis. Johns Hopkins Hosp. Bull. 49 (1931) 17-27
49. Swanson J.A., and Watts C. Macropinocytosis. Trends Cell Biol. 5 (1995) 424-428
50. West M.A., Bretscher M.S., and Watts C. Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. J. Cell. Biol. 109 (1989) 2731-2739
51. Racoosin E.L., and Swanson J.A. M-CSF-induced macropinocytosis increases solute endocytosis but not receptor-mediated endocytosis in mouse macrophages. J. Cell Sci. 102 (1992) 867-880
52. Racoosin E.L., and Swanson J.A. Macrophage colony-stimulating factor (rM-CSF) stimulates pinocytosis in bone marrow-derived macrophages. J. Exp. Med. 170 (1989) 1635-1648
53. Phaire-Washington L., Wang E., and Silverstein S.C. Phorbol myristate acetate stimulates pinocytosis and membrane spreading in mouse peritoneal macrophages. Cell Biol. 86 (1980) 634-640
54. Swanson J.A. Phorbol esters stimulate macropinocytosis and solute flow through macrophages. J. Cell Sci. 94 (1989) 135-142
55. Racoosin E.L., and Swanson J.A. Macropinosome maturation and fusion with tubular lysosomes in macrophages. J. Cell Biol. 121 (1993) 1011-1020
56. Munniksma J., Noteborn M., Kooistra T., Stienstra S., Bouma J.M., Gruber M., Brouwer A., Praaning-van Dalen D., and Knook D.L. Fluid endocytosis by rat liver and spleen. Experiments with 125I-labelled poly(vinylpyrrolidone) in vivo. Biochem. J. 192 (1980) 613-621
57. Kjeken R., Mousavi S.A., Brech A., Gjoen T., and Berg T. Fluid phase endocytosis of [125I]iodixanol in rat liver parenchymal, endothelial and Kupffer cells. Cell Tissue Res. 304 (2001) 221-230
58. Van Eck M., Pennings M., Hoekstra M., Out R., and Van Berkel T.J. Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis. Curr. Opin. Lipidol. 16 (2005) 307-315
59. Higgins C.F. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8 (1992) 67-113
60. Rye K.A., and Barter P.J. Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 421-428
61. Costet P., Luo Y., Wang N., and Tall A.R. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 275 (2000) 28240-28245
62. Schwartz K., Lawn R.M., and Wade D.P. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem. Biophys. Res. Commun. 274 (2000) 794-802
63. Lawn R.M., Wade D.P., Couse T.L., and Wilcox J.N. Localization of human ATP-binding cassette transporter 1 (ABC1) in normal and atherosclerotic tissues. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 378-385
64. Van Eck M., Bos I.S., Kaminski W.E., Orso E., Rothe G., Twisk J., Bottcher A., Van Amersfoort E.S., Christiansen-Weber T.A., Fung-Leung W.P., Van Berkel T.J., and Schmitz G. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc. Natl. Acad. Sci. USA 99 (2002) 6298-6303
65. Aiello R.J., Brees D., Bourassa P.A., Royer L., Lindsey S., Coskran T., Haghpassand M., and Francone O.L. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 630-637
66. Van Eck M., Singaraja R.R., Ye D., Hildebrand R.B., James E.R., Hayden M.R., and Van Berkel T.J. Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 929-934
67. Klucken J., Buchler C., Orso E., Kaminski W.E., Porsch-Ozcurumez M., Liebisch G., Kapinsky M., Diederich W., Drobnik W., Dean M., Allikmets R., and Schmitz G. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc. Natl. Acad. Sci. USA 97 (2000) 817-822
68. Hoekstra M., Kruijt J.K., Van Eck M., and Van Berkel T.J. Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells. J. Biol. Chem. 278 (2003) 25448-25453
69. Venkateswaran A., Laffitte B.A., Joseph S.B., Mak P.A., Wilpitz D.C., Edwards P.A., and Tontonoz P. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc. Natl. Acad. Sci. USA 97 (2000) 12097-12102
70. Venkateswaran A., Repa J.J., Lobaccaro J.M., Bronson A., Mangelsdorf D.J., and Edwards P.A. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J. Biol. Chem. 275 (2000) 14700-14707
71. Jessup W., Gelissen I.C., Gaus K., and Kritharides L. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr. Opin. Lipidol. 17 (2006) 247-257
72. Kennedy M.A., Barrera G.C., Nakamura K., Baldan A., Tarr P., Fishbein M.C., Frank J., Francone O.L., and Edwards P.A. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 1 (2005) 121-131
73. Wang N., Lan D., Chen W., Matsuura F., and Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. USA 101 (2004) 9774-9779
74. Gelissen I.C., Harris M., Rye K.A., Quinn C., Brown A.J., Kockx M., Cartland S., Packianathan M., Kritharides L., and Jessup W. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 534-540
75. Baldan A., Tarr P., Lee R., and Edwards P.A. ATP-binding cassette transporter G1 and lipid homeostasis. Curr. Opin. Lipidol. 17 (2006) 227-232
76. Wang N., Ranalletta M., Matsuura F., Peng F., and Tall A.R. LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1310-1316
77. Lorkowski S., Kratz M., Wenner C., Schmidt R., Weitkamp B., Fobker M., Reinhardt J., Rauterberg J., Galinski E.A., and Cullen P. Expression of the ATP-binding cassette transporter gene ABCG1 (ABC8) in Tangier disease. Biochem. Biophys. Res. Commun. 283 (2001) 821-830
78. Out R., Hoekstra M., Hildebrand R.B., Kruit J.K., Meurs I., Li Z., Kuipers F., Van Berkel Th.J.C., and Van Eck M. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20 July (2006) (Epub ahead of print)
79. Dean M., and Allikmets R. Evolution of ATP-binding cassette transporter genes. Curr. Opin. Genet. Dev. 5 (1995) 779-785
80. Dean M., Rzhetsky A., and Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 11 (2001) 1156-1166
81. Langmann T., Mauerer R., and Schmitz G. Human ATP-binding cassette transporter TaqMan low-density array: analysis of macrophage differentiation and foam cell formation. Clin. Chem. 52 (2006) 310-313
82. Kaminski W.E., Piehler A., Pullmann K., Porsch-Ozcurumez M., Duong C., Bared G.M., Buchler C., and Schmitz G. Complete coding sequence, promoter region, and genomic structure of the human ABCA2 gene and evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 281 (2001) 249-258
83. Kaminski W.E., Wenzel J.J., Piehler A., Langmann T., and Schmitz G. ABCA6, a novel a subclass ABC transporter. Biochem. Biophys. Res. Commun. 285 (2001) 1295-1301
84. Kaminski W.E., Orso E., Diederich W., Klucken J., Drobnik W., and Schmitz G. Identification of a novel human sterol-sensitive ATP-binding cassette transporter (ABCA7). Biochem. Biophys. Res. Commun. 273 (2000) 532-538
85. Broccardo C., Osorio J., Luciani M.F., Schriml L.M., Prades C., Shulenin S., Arnould I., Naudin L., Lafargue C., Rosier M., Jordan B., Mattei M.G., Dean M., Denefle P., and Chimini G. Comparative analysis of the promoter structure and genomic organization of the human and mouse ABCA7 gene encoding a novel ABCA transporter. Cytogenet. Cell Genet. 92 (2001) 264-270
86. Wang N., Lan D., Gerbod-Giannone M., Linsel-Nitschke P., Jehle A.W., Chen W., Martinez L.O., and Tall A.R. ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux. J. Biol. Chem. 278 (2003) 42906-42912
87. Abe-Dohmae S., Ikeda Y., Matsuo M., Hayashi M., Okuhira K., Ueda K., and Yokoyama S. Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein. J. Biol. Chem. 279 (2004) 604-611
88. Piehler A., Kaminski W.E., Wenzel J.J., Langmann T., and Schmitz G. Molecular structure of a novel cholesterol-responsive A subclass ABC transporter, ABCA9. Biochem. Biophys. Res. Commun. 295 (2002) 408-416
89. Wenzel J.J., Kaminski W.E., Piehler A., Heimerl S., Langmann T., and Schmitz G. ABCA10, a novel cholesterol-regulated ABCA6-like ABC transporter. Biochem. Biophys. Res. Commun. 306 (2003) 1089-1098
90. Linsel-Nitschke P., Jehle A.W., Shan J., Cao G., Bacic D., Lan D., Wang N., and Tall A.R. Potential role of ABCA7 in cellular lipid efflux to apoA-I. J. Lipid Res. 46 (2005) 86-92
91. Higgins C.F., and Gottesman M.M. Is the multidrug transporter a flippase?. Trends Biochem. Sci. 17 (1992) 18-21
92. Batetta B., Mulas M.F., Petruzzo P., Putzolu M., Bonatesta R.R., Sanna F., Cappai A., Brotzu G., and Dessi S. Opposite pattern of MDR1 and caveolin-1 gene expression in human atherosclerotic lesions and proliferating human smooth muscle cells. Cell Mol. Life Sci. 58 (2001) 1113-1120
93. Debry P., Nash E.A., Neklason D.W., and Metherall J.E. Role of multidrug resistance P-glycoproteins in cholesterolesterification. J. Biol. Chem. 272 (1997) 1026-1031
94. Luker G.D., Nilsson K.R., Covey D.F., and Piwnica-Worms D. Multidrug resistance (MDR1) P-glycoprotein enhances esterification of plasma membrane cholesterol. J. Biol. Chem. 274 (1999) 6979-6991
95. Issandou M., and Gramd-Perret T. Multidrug resistance P-glycoprotein is not involved in cholesterol esterification. Biochem. Biophys. Res. Commun. 279 (2000) 369-377
96. Le Goff W., Settle M., Greene D.J., Morton R.E., and Smith J.D. Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasis. J. Lipid Res. 47 (2006) 51-58
97. Smit J.J., Schinkel A.H., Oude Elferink R.P., Groen A.K., Wagenaar E., van Deemter L., Mol C.A., Ottenhoff R., van der Lugt N.M., van Roon M.A., et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75 (1993) 451-462
98. Engel T., Lorkowski S., Lueken A., Rust S., Schluter B., Berger G., Cullen P., and Assmann G. The human ABCG4 gene is regulated by oxysterols and retinoids in monocyte-derived macrophages. Biochem. Biophys. Res. Commun. 288 (2001) 483-488
99. Cserepes J., Szentpetery Z., Seres L., Ozvegy-Laczka C., Langmann T., Schmitz G., Glavinas H., Klein I., Homolya L., Varadi A., Sarkadi B., and Elkind N.B. Functional expression and characterization of the human ABCG1 and ABCG4 proteins: indications for heterodimerization. Biochem. Biophys. Res. Commun. 320 (2004) 860-867
100. Bretscher M.S. Asymmetrical lipid bilayer structure for biological membranes. Nat. New Biol. 236 (1972) 11-12
101. Daleke D.L. Regulation of transbilayer plasma membrane phospholipid asymmetry. J. Lipid Res. 44 (2003) 233-242
102. Holthuis J.C., and Levine T.P. Lipid traffic: floppy drives and a superhighway. Nat. Rev. Mol. Cell Biol. 6 (2005) 209-220
103. Sims P.J., and Wiedmer T. Unraveling the mysteries of phospholipid scrambling. Thromb. Haemost. 86 (2001) 266-275
104. Dekkers D.W., Comfurius P., van Gool R.G., Bevers E.M., and Zwaal R.F. Multidrug resistance protein 1 regulates lipid asymmetry in erythrocyte membranes. Biochem. J. 350 (2000) 531-535
105. Dekkers D.W., Comfurius P., Schroit A.J., Bevers E.M., and Zwaal R.F. Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: outward-directed transport by the multidrug resistance protein 1 (MRP1). Biochemistry 37 (1998) 14833-14837
106. Van Helvoort A., Smith A.J., Sprong H., Fritzsche I., Schinkel A.H., Borst P., and van Meer G. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87 (1996) 507-517
107. Bosch I., Dunussi-Joannopoulos K., Wu R.L., Furlong S.T., and Croop J. Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein. Biochemistry 36 (1997) 5685-5694
108. Eckford P.D., and Sharom F.J. The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids. Biochem. J. 389 (2005) 517-526
109. Smith A.J., Timmermans-Hereijgers J.L., Roelofsen B., Wirtz K.W., van Blitterswijk W.J., Smit J.J., Schinkel A.H., and Borst P. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett. 354 (1994) 263-266
110. Kalin N., Fernandes J., Hrafnsdottir S., and van Meer G. Natural phosphatidylcholine is actively translocated across the plasma membrane to the surface of mammalian cells. J. Biol. Chem. 279 (2004) 33228-33236
111. Hamon Y., Broccardo C., Chambenoit O., Luciani M.F., Toti F., Chaslin S., Freyssinet J.M., Devaux P.F., McNeish J., Marguet D., and Chimini G. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat. Cell Biol. 2 (2000) 399-406
112. Chambenoit O., Hamon Y., Marguet D., Rigneault H., Rosseneu M., and Chimini G. Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter. J. Biol. Chem. 276 (2001) 9955-9960
113. Smith J.D., Waelde C., Horwitz A., and Zheng P. Evaluation of the role of phosphatidylserine translocase activity in ABCA1-mediated lipid efflux. J. Biol. Chem. 277 (2002) 17797-17803
114. Wang N., Silver D.L., Thiele C., and Tall A.R. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J. Biol. Chem. 276 (2001) 23742-23747
115. Kobayashi A., Takanezawa Y., Hirata T., Shimizu Y., Misasa K., Kioka N., Arai H., Ueda K., and Matsuo M. Efflux of sphingomyelin, cholesterol and phosphatidylcholine by ABCG1. J. Lipid Res. 15 May (2006) (Epub ahead of print)
116. Berge K.E., Tian H., Graf G.A., Yu L., Grishin N.V., Schultz J., Kwiterovich P., Shan B., Barnes R., and Hobbs H.H. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290 (2000) 1771-1775
117. Weng J., Mata N.L., Azarian S.M., Tzekov R.T., Birch D.G., and Travis G.H. Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice. Cell 98 (1999) 13-23
118. Pomorski T., Holthuis J.C., Herrmann A., and van Meer G. Tracking down lipid flippases and their biological functions. J. Cell Sci. 117 (2004) 805-813
119. van Meer G., and Sprong H. Membrane lipids and vesicular traffic. Curr. Opin. Cell Biol. 16 (2004) 373-378
120. Sprong H., van der Sluijs P., and van Meer G. How proteins move lipids and lipids move proteins. Nat. Rev. 2 (2001) 504-513
121. Muller P., Pomorski T., and Herrmann A. Incorporation of phospholipid analogues into the plasma membrane affects ATP-induced vesiculation of human erythrocyte ghosts. Biochem. Biophys. Res. Commun. 199 (1994) 881-887
122. Farge E. Increased vesicle endocytosis due to an increase in the plasma membrane phosphatidylserine concentration. Biophys. J. 69 (1995) 2501-2506
123. Farge E., Ojcius D.M., Subtil A., and Dautry-Varsat A. Enhancement of endocytosis due to aminophospholipid transport across the plasma membrane of living cells. Am. J. Physiol. 276 (1999) C725-C733
124. Pomorski T., Lombardi R., Riezman H., Devaux P.F., van Meer G., and Holthuis J.C. Drs2p-related P-type ATPases Dnf1p and Dnf2p are required for phospholipid translocation across the yeast plasma membrane and serve a role in endocytosis. Mol. Biol. Cell 14 (2003) 1240-1254
125. Zha X., Genest Jr. J., and McPherson R. Endocytosis is enhanced in Tangier fibroblasts: possible role of ATP-binding cassette protein A1 in endosomal vesicular transport. J. Biol. Chem. 276 (2001) 39476-39483
126. Alder-Baerens N., Muller P., Pohl A., Korte T., Hamon Y., Chimini G., Pomorski T., and Herrmann A. Headgroup-specific exposure of phospholipids in ABCA1-expressing cells. J. Biol. Chem. 280 (2005) 26321-26329
127. Buono C., Waldo S.W., and Kruth H.S. LXRs inhibit cholesterol accumulation and LDL uptake by macropinocytosis in macrophages differentiated from human monocytes with M-CSF in vitro. Arterioscler. Thromb. Vasc. Biol. 26 (2006) e-48
128. Pennings M., Hildebrand R.B., Van Berkel Th.J.C., Groen A.K., and Van Eck M. Macrophage ABCB4 deficiency promotes atherosclerotic lesion development in LDL receptor knockout mice. Circulation 112 (2005) SII-257
129. Pennings M., Hildebrand R.B., Van Berkel Th.J.C., Groen A.K., and Van Eck M. Macrophage ABCB4 deficiency promotes atherosclerotic lesion development in LDL receptor knockout mice. Atherosclerosis Suppl. 7 (2006) 319-320
130. Fonarow G.C., and Watson K.E. Effective strategies for long-term statin use. Am. J. Cardiol. 92 (2003) 27I-34I
131. Kastelein J.J. The future of lipid-lowering therapy: the big picture. Neth. J. Med. 61 (2003) 35-39
132. Graham T.R. Flippases and vesicle-mediated protein transport. Trends Cell Biol. 14 (2004) 670-677